tezosentan has been researched along with Meconium Aspiration Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fischer, V; Fratz, S; Geiger, R; Kleinsasser, A; Loeckinger, A; Maier, S; Navarro-Psiha, S; Neu, N; Pajk, W; Treml, B | 1 |
| Fischer, V; Geiger, R; Kleinsasser, A; Loeckinger, A; Meier, S; Neu, N; Pajk, W; Stein, JI; Treml, B | 1 |
2 other study(ies) available for tezosentan and Meconium Aspiration Syndrome
| Article | Year |
|---|---|
Tezosentan decreases pulmonary artery pressure and improves survival rate in an animal model of meconium aspiration.
Topics: Animals; Blood Pressure; Disease Models, Animal; Endothelin Receptor Antagonists; Humans; Hypertension, Pulmonary; Infant, Newborn; Meconium Aspiration Syndrome; Pulmonary Artery; Pulmonary Gas Exchange; Pyridines; Survival Analysis; Sus scrofa; Tetrazoles; Vascular Resistance | 2006 |
Intravenous tezosentan improves gas exchange and hemodynamics in acute lung injury secondary to meconium aspiration.
Topics: Analysis of Variance; Animals; Hemodynamics; Humans; Iloprost; Infant, Newborn; Injections, Intravenous; Meconium Aspiration Syndrome; Pulmonary Gas Exchange; Pyridines; Respiratory Distress Syndrome; Swine; Tetrazoles | 2008 |